English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 April 2020, 19:00 HKT/SGT
Share:
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes

SYDNEY, AU, Apr 28, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates.


A Novotech Client COVID-19 trial was just approved in under 9 days in South Korea.

The South Korean Ministry of Food and Drug Safety (MFDS) has announced "GO-expedite" program where they are expediting the review process for COVID-19 treatment and vaccine trials with specific timelines.

Other countries are also fast-tracking COVID-19 trial reviews including:
-- India: review/approval in 10 working days
-- Thailand: review/approval in 15 working days
-- Malaysia: review/approval in 20 working days

Novotech Executive Director, Asia Operations, Dr. Yooni Kim said she was pleased to see such a rapid response in the region to support vital research.

"We are seeing an increase in demand from biotechnology sponsors for studies in the Asia-Pacific region because of the speed and quality available here. This expedited review process will further support the race for COVID-19 treatments."

For the latest updates on the Asia-Pacific clinical trial landscape see our Data Bulletins (updated weekly).
View and download COVID-19 Data Bulletins here: https://novotech-cro.com/covid-19-notice

About Novotech - https://novotech-cro.com

Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific. Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies. Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management.

Novotech obtained the ISO 27001 certification which is the best-known standard in the ISO family providing requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media contact:
David James
communications@novotech-cro.com
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427


Topic: Press release summary Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Goldenstone Acquisition Limited (Ticker: GDST) Announces Intent to Merge with ESG Packaging Innovator Deluxe Technology Group, Targeting 2026 NASDAQ Listing  
Feb 4, 2026 22:00 HKT/SGT
Military Metals Drills 23.5 Meters of 3.3 g/t Gold Including 4.0 Meters of 10.52 g/t Gold and 1.9 Meters of 2.53% Antimony at Flagship Trojarova Project, Europe  
Feb 4, 2026 21:59 HKT/SGT
Japantastics Launches Global Curator Platform Bringing Japan Craftsmanship to the World  
Wednesday, February 4, 2026 9:00:00 PM
The 55-Point Gap: Measuring What Matters in Automotive Impact  
Wednesday, February 4, 2026 5:00:00 PM
Mitsubishi Heavy Industries Announces Large Order Intake, Revenue, and Profit Growth in First Three Quarters, Raises Full-Year Guidance  
Wednesday, February 4, 2026 4:13:00 PM
Airwheel Introduces AI-Driven Rideable Smart Cabin Suitcase Solutions for the Next Generation of Global Travel  
Feb 4, 2026 14:00 HKT/SGT
Honda Co-developing Automobile SoC with U.S.-based Mythic to Accelerate Research to Enhance AI Computing Performance and Energy Efficiency
  
Wednesday, February 4, 2026 10:32:00 AM
Casa Minerals Inc. Announces Closing of First Tranche of Private Placement  
Feb 4, 2026 07:59 HKT/SGT
DENSO Announces Third Quarter Financial Results  
Tuesday, February 3, 2026 6:36:00 PM
FWD Group survey reveals over 70 per cent of Asia's middle-class feel anxiety about financial wellbeing, preventing longer-term planning  
Tuesday, February 3, 2026 2:13:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575